Related by context. Frequent words. (Click for all words.) 67 INCB# [002] 64 daclizumab 63 AP# [003] 63 AVEO 63 carfilzomib 63 Phase 2b trial 63 satraplatin 63 perifosine 63 XL# [003] 63 MGCD# [001] 62 Phase III trials 62 FOLOTYN 62 elesclomol 61 HspE7 61 Phase 2b study 61 nimotuzumab 61 voreloxin 61 fidaxomicin 61 Phase Ib 61 Phase 1b 60 sorafenib 60 CYT# 60 orBec R 60 Phase III clinical 60 picoplatin 60 Phase IIb clinical 60 Phase III clinical trials 60 RG# [001] 60 Phase IIb trial 60 BiovaxID 60 Ceplene 60 tolerability profile 59 pivotal Phase III 59 sunitinib 59 mipomersen 59 ADVEXIN 59 IDX# 59 oncology indications 59 IMGN# 59 Phase 2b 59 ambrisentan 59 AMR# 58 cancer immunotherapy 58 preclinical studies 58 clinical trials 58 Marqibo 58 ASA# 58 RDEA# 58 Phase 2b clinical 58 Phase IIb 58 HCV infection 58 randomized Phase 58 Locteron 58 bavituximab 58 VELCADE 58 MDV# 58 tolerability 57 Hematide 57 APF# 57 metastatic melanoma 57 Phase IIa trial 57 ISIS # 57 panitumumab 57 myelofibrosis 57 ofatumumab 57 preclinical 57 hematological malignancies 57 LymphoStat B 57 hematologic malignancies 57 Oncophage 57 Nexavar 57 NSCLC 57 Phase 2a clinical 57 Cimzia 57 Bronchitol 57 linaclotide 56 Mozobil 56 relapsing remitting multiple sclerosis 56 telaprevir 56 ENMD 56 Defibrotide 56 humanized monoclonal antibody 56 orBec ® 56 Phase 2a 56 telbivudine 56 T DM1 56 Opexa 56 dose escalation 56 hepatocellular carcinoma 56 CUDC 56 cethromycin 56 temozolomide 56 PROVENGE 55 kinase inhibitor 55 Phase III 55 MGCD# [002] 55 Santhera 55 alemtuzumab 55 dasatinib 55 TYSABRI 55 HEPLISAV